Taking into account that patients with AGS have increased IFN-α in CSF and peripheral blood, Rice and colleagues proposed in 2013 that the interferon signature could facilitate the diagnosis of AGS, as a possible biomarker. This evidence concerns the gene IFNA1 and Aicardi-Goutieres syndrome.